Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Methodist Hospital Research Institute
Hoffmann-La Roche
Bayer
Jazz Pharmaceuticals
Daiichi Sankyo
OHSU Knight Cancer Institute
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Elevation Oncology
Xencor, Inc.
Aurigene Discovery Technologies Limited
Exelixis
pharmaand GmbH
M.D. Anderson Cancer Center
Hoffmann-La Roche
OncoNano Medicine, Inc.
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Northwestern University
National Institutes of Health Clinical Center (CC)
Duke University
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
Cambridge University Hospitals NHS Foundation Trust
Eli Lilly and Company
Washington University School of Medicine
Wake Forest University Health Sciences
City of Hope Medical Center
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
UNICANCER
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Bayer
St. Luke's-Roosevelt Hospital Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center